|
With only a few days until the webinar, don't forget to register for what promises to be an enlightening session.
The Built Environment of the Hospital and Nosocomial Infections: Sources and Transmission Routes
13 August 2025 @ 12.00 CET*
We are delighted to invite you to the next webinar held in collaboration with the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Explore how hospital design directly impacts infection control in this insightful webinar featuring two leading experts.
• Professor Margreet Vos highlights why hospital design matters in preventing nosocomial infections.
• Professor Paul Anantharajah Tambyah reflects on lessons from the pandemic and how the built environment can be optimised for future resilience.
Join us to understand how architecture, infrastructure, and infection prevention intersect in modern healthcare.
REGISTER
*Check start time by time zone
**Certificates of attendance will be available
Moderators
Prof. Souha Kanj (ISAC President / American University of Beirut Medical Centre, Lebanon)
Prof. Robert Skov (ESCMID President / Statens Serum Institut, Denmark)
SPEAKER BIOS
Prof. Dr Margreet C. Vos is a Clinical Microbiologist and is a professor of healthcare related infections at the ErasmusMC, Rotterdam, the Netherlands. She has presented more than 200 invited lectures nationally and internationally and has around 235 peer reviewed publications (H index 35 (2022)), on infection prevention, in particular MSSA/MRSA, the Search and Destroy strategy, hand hygiene, outbreaks, transmission, innate environment, hospital environment and hospital design and endoscope related contamination and infections. She is member or chair of many (inter)national committees or working groups on infection prevention in general or specific on MRSA, hospital design infection prevention. For many years she initiated and chaired a national working group (HIP) as part of the Dutch Society of Medical Microbiology (NVMM) and initiated, developed and chaired the committee on infection control national guideline on the organization and quality of hospital infection prevention and developed audits for quality of hospital infection prevention. Currently, she is a member of two international guideline committees: The ESCMID-HIS guideline on Behavior and Rituals in the Operation Theatre and the ESCMID-EUCIC Guideline on Multi-Drug-Resistant Gram-negatives. She was the project-leader of an international (UK FR NL) JPI MACOTRA consortium on (un)success of MRSA clones. She is the former chair and currently the scientific officer of ESGNI (ESCMID) and chair of the ISAC S. aureus Working Group.
Prof. Paul Ananth Tambyah is currently Professor of Medicine at the National University of Singapore and Senior Consultant Infectious Diseases Physician at the National University Health System. He is also visiting consultant to the National Center for Infectious Diseases and the Singapore Armed Forces. He is immediate Past President of the Asia Pacific Society of Clinical Microbiology and Infection and also immediate Past President of the International Society for Infectious Diseases. His research interests are device associated infection and emerging infectious diseases.
|
